UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2004, ISBN 9780781735261, xix, 856
Book
1997, 2nd ed., ISBN 0340557931, xvi, 1149
Book
Annals of oncology, ISSN 0923-7534, 04/2013, Volume 24, Issue 4, pp. 857 - 877
mantle cell lymphoma | malignant lymphoma guidelines | T-cell lymphoma | marginal zone lymphoma | EUROPEAN-MCL-NETWORK | PROSPECTIVE RANDOMIZED-TRIAL | PROGRESSION-FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | LOW-GRADE LYMPHOMA | PHASE-II TRIAL | INTERNATIONAL PROGNOSTIC INDEX | HIGH-DOSE THERAPY | NON-HODGKINS-LYMPHOMA | MINIMAL RESIDUAL DISEASE | Mantle cell lymphoma | Marginal zone lymphoma | Malignant lymphoma guidelines | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Guidelines as Topic | World Health Organization | Europe | Humans | Lymphoma, Mantle-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - therapy | Lymphoma, Mantle-Cell - diagnosis | Lymphoma, Mantle-Cell - therapy | Lymphoma, B-Cell, Marginal Zone - diagnosis | Lymphoma, T-Cell - therapy | Lymphoma, T-Cell - diagnosis | Lymphoma, T-Cell - pathology | Lymphoma, B-Cell, Marginal Zone - pathology | Index Medicus
Journal Article
6.
Lymphoma
Primary care, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Diffuse large B cell | T cell | Burkitt | Non-Hodgkin | Hodgkin | Follicular | Lymphoma | MALT | Medicine, General & Internal | Primary Health Care | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Decision Making | Lymphoma - therapy | Humans | Quality of Life | Lymphoma - pathology | Antineoplastic Agents - therapeutic use | Disease Management | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 2002, Volume 13, Issue 1, pp. 140 - 149
Diagnostic reliability | Peripheral T-cell lymphoma | Clinicopathologic correlations | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Lymphoma, T-Cell, Peripheral - drug therapy | Reproducibility of Results | Prognosis | Humans | Middle Aged | Male | Survival Rate | Lymphoma, T-Cell, Peripheral - epidemiology | Lymphoma, T-Cell, Peripheral - diagnosis | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Lymphoma, Non-Hodgkin - classification | Index Medicus
Journal Article
Pediatric blood & cancer, ISSN 1545-5009, 08/2020, Volume 67, Issue 8, pp. e28416 - n/a
peripheral T‐cell lymphoma | non‐Hodgkin lymphoma | follicular lymphoma | rare | marginal zone lymphoma | Pediatrics | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Stem cell transplantation | Remission | Anaplastic large-cell lymphoma | Children | Lymphoma | Hematopoietic stem cells | Hodgkin's disease | Hemopoiesis | Index Medicus | Cancer and Oncology | Pediatrik | Cancer och onkologi
Journal Article
Blood, ISSN 0006-4971, 01/2007, Volume 109, Issue 1, pp. 331 - 338
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Up-Regulation | Prognosis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Lymphoma, Large B-Cell, Diffuse - metabolism | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Transmembrane Activator and CAML Interactor Protein - metabolism | Tumor Necrosis Factor Ligand Superfamily Member 13 - biosynthesis | Retrospective Studies | Neoplasm Proteins - genetics | Neutrophils - metabolism | Protein Structure, Tertiary | Lymphoma, B-Cell - metabolism | Lymphoma, B-Cell - mortality | Lymphoma, Large B-Cell, Diffuse - pathology | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Kaplan-Meier Estimate | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Proteoglycans - metabolism | Burkitt Lymphoma - metabolism | Lymphoma, Large B-Cell, Diffuse - mortality | B-Cell Maturation Antigen - metabolism | Lymphoma, Non-Hodgkin - metabolism | Lymphoma, B-Cell - pathology | Survival Analysis | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Lymphoma, Non-Hodgkin - mortality | Index Medicus | Abridged Index Medicus
Journal Article